U.S. Oil and Gas Stock News

BlackSky Technology FY 2025 earnings snapshot BlackSky Technology (BKSY) has capped FY 2025 with fourth quarter revenue of US$35.2 million and a basic EPS loss of US$0.02, while trailing 12 month revenue sits at US$106.6 million against a net loss of US$70.3 million. Over recent quarters, the company has seen revenue move from US$30.4 million in Q4 2024 to US$35.2 million in Q4 2025, with basic EPS losses ranging from US$1.02 in Q4 2024 to US$0.02 in Q4 2025. Investors may weigh those...

Redwire FY 2025 results: revenue climbs while losses remain heavy Redwire (RDW) has capped FY 2025 with Q4 revenue of US$108.8 million and a basic EPS loss of US$0.58, alongside trailing 12 month figures showing US$335.4 million in revenue and a basic EPS loss of US$2.28. The company has seen revenue move from US$69.6 million in Q4 2024 to US$108.8 million in Q4 2025, while quarterly basic EPS has remained in loss making territory over the same period. With losses still sizeable even as the...

Zevia PBC (ZVIA) just wrapped up FY 2025 with Q4 revenue of US$37.9 million and a basic EPS loss of US$0.02, alongside a trailing twelve month loss of US$9.9 million on revenue of US$161.3 million. Over recent quarters, the company has seen quarterly revenue move between US$36.4 million and US$44.5 million, while basic EPS losses have ranged from US$0.01 to US$0.10 per share. Together, these figures present a picture of relatively steady sales but still negative earnings. For investors, the...

Penumbra (PEN) has wrapped up FY 2025 with fourth quarter revenue of US$385.4 million and basic EPS of US$1.21, set against very large reported earnings growth over the past year and a trailing net margin of 12.7%. The company has seen quarterly revenue move from US$315.5 million in Q4 2024 to US$385.4 million in Q4 2025, while basic EPS stepped from US$0.88 to US$1.21 over the same period. On a trailing 12 month basis, revenue reached about US$1.4 billion with basic EPS of US$4.57. With...

Latest FY 2025 Results Set Up a Fresh Look at Novavax Novavax (NVAX) has wrapped up FY 2025 with fourth quarter revenue of US$147.1 million and basic EPS of US$0.11, alongside trailing 12 month revenue of US$1.1 billion and EPS of US$2.72 that point to a very different earnings profile than a year ago. Over the past six quarters, the company has seen revenue move from US$88.3 million in Q4 2024 to US$666.7 million in Q1 2025, US$239.2 million in Q2, US$70.4 million in Q3, and now US$147.1...

Photronics (PLAB) has just posted Q1 2026 results with revenue of US$225.1 million and basic EPS of US$0.74, setting the tone for how the year might shape up on both the top and bottom line. The company has seen revenue move from US$212.1 million in Q1 2025 to US$225.1 million in Q1 2026, while basic EPS has shifted from US$0.69 to US$0.74 over the same period. This gives investors a clear read on how sales and per share profitability are tracking into the new fiscal year as margins come into...

Playtika Holding (PLTK) closed FY 2025 with Q4 revenue of US$678.8 million and a basic EPS loss of US$0.82, while trailing twelve month EPS stood at a loss of US$0.55 on revenue of about US$2.8 billion. The company reported quarterly revenue ranging from US$706 million in Q1 2025 to US$678.8 million in Q4 2025, with EPS moving from US$0.08 to US$0.11 earlier in the year before swinging to a loss in the final quarter. Over the same period, trailing twelve month EPS shifted from US$0.58 in Q3...

Warby Parker FY 2025 results: profitability holds on a trailing basis as Q4 swings back to a loss Warby Parker (WRBY) closed FY 2025 with Q4 revenue of US$212 million and a basic EPS loss of US$0.05, while on a trailing twelve month view the business remained just in the black with basic EPS of US$0.01 on US$871.9 million of revenue. Over the last six reported quarters, quarterly revenue has moved from US$190.6 million in Q4 2024 to a range between US$211.9 million and US$223.8 million...

Option Care Health reported strong 2025 results, with significant revenue growth and expanded service offerings across its infusion network. The company increased its footprint of infusion suites and invested in automation and AI to support operational efficiency. Management highlighted disciplined capital allocation, including targeted M&A, while managing headwinds from biosimilar conversions and reimbursement pressures. Option Care Health (NasdaqGS:OPCH) is coming off a year of solid...

Latest FY 2025 Earnings Snapshot Global Net Lease (GNL) has just wrapped up FY 2025 with fourth quarter revenue of US$116.9 million and basic EPS of US$0.20, while funds from operations came in at a loss of US$52.3 million, setting a mixed tone for income focused REIT investors watching the headline numbers. Over recent quarters the company has seen revenue move from US$199.1 million in Q4 2024 to US$132.4 million in Q1 2025, US$124.9 million in Q2 2025, US$121.0 million in Q3 2025 and...

Entrada Therapeutics (TRDA) closed out FY 2025 with Q4 revenue of US$1.3 million and a basic EPS loss of US$0.94, while trailing twelve month figures showed revenue of US$25.4 million and a basic EPS loss of US$3.47. Over the past few quarters, the company has seen quarterly revenue move from US$37.4 million in Q4 2024 to US$20.6 million in Q1 2025, then to US$1.9 million, US$1.6 million and US$1.3 million in Q2, Q3 and Q4 2025. Basic EPS shifted from a profit of US$0.03 in Q4 2024 to losses...

Baidu (NasdaqGS:BIDU) has wrapped up FY 2025 with fourth quarter revenue of C¥32.7b and basic EPS of C¥5.24, capping a year in which trailing twelve month revenue came in at C¥129.1b and basic EPS at C¥16.40. Over recent quarters the company has seen quarterly revenue move between C¥32.5b and C¥32.7b, while basic EPS has ranged from a loss of C¥33.12 in Q3 2025 to C¥22.44 in Q1 2025. This has occurred alongside a trailing net profit margin of 6.4% compared with 15.3% a year earlier, which...

Alector (ALEC) has laid out its FY 2025 story with fourth quarter revenue of US$6.2 million, a basic EPS loss of US$0.34 and net income loss of US$37.3 million, set against trailing 12 month revenue of US$21.0 million and a full year EPS loss of US$1.39 on a US$142.9 million net loss. Over recent quarters, the company has seen revenue move between US$3.3 million and US$7.9 million with basic EPS losses ranging from US$0.30 to US$0.41 per quarter, while the prior year fourth quarter showed...

RxSight (RXST) has just reported its FY 2025 numbers with Q4 revenue of US$32.6 million and a basic EPS loss of US$0.22, while on a trailing twelve month basis revenue was US$134.5 million and basic EPS was a loss of US$0.95, keeping the focus firmly on how quickly the business can scale toward profitability. Over the past few quarters, the company has seen revenue range from US$30.3 million to US$40.2 million and basic EPS losses move between US$0.15 and US$0.29, which puts a spotlight on...

HCI Group (HCI) has capped FY 2025 with fourth quarter revenue of US$246.2 million and basic EPS of US$7.50, rounding out a year where trailing twelve month revenue reached US$900.9 million and EPS came in at US$24.58. Over the past few quarters, the company has seen revenue move from US$161.9 million and EPS of roughly US$0.22 in Q4 2024 to US$216.4 million and EPS of US$6.47 in Q1 2025, US$221.9 million and EPS of US$6.08 in Q2, and US$216.4 million with EPS of about US$5.06 in Q3. This...

QXO (QXO) has just reported its FY 2025 numbers, with Q4 revenue of US$2.2 billion and a basic EPS loss of US$0.13 per share on net income excluding extra items of a US$90.2 million loss. Over recent quarters the company has seen revenue move from US$13.5 million and EPS of US$0.03 loss in Q1 2025 to US$2.7 billion and EPS of US$0.24 loss in Q3 2025, before landing at US$2.2 billion and EPS of US$0.13 loss in Q4. Trailing twelve month revenue sits at US$6.8 billion and EPS at US$0.46 loss,...

GoodRx Holdings (GDRX) FY 2025 Earnings Snapshot GoodRx Holdings (GDRX) closed out FY 2025 with Q4 revenue of US$194.8 million and basic EPS of US$0.02. Trailing twelve month figures came in at US$796.9 million of revenue and EPS of US$0.09 on net income of US$30.4 million. The company has seen quarterly revenue move from US$198.6 million in Q4 2024 to a range of US$195.3 million to US$203.1 million through 2025, with EPS running between US$0.00 and US$0.04 across those same periods. With...

C3.ai (AI) just posted its Q3 2026 numbers, with revenue of US$53.3 million and a basic EPS loss of US$0.94, while trailing twelve month revenue came in at US$307.4 million and EPS at a loss of US$3.17. Over the last six reported quarters, the company has seen quarterly revenue move from US$94.3 million in Q2 2025 to US$53.3 million in Q3 2026, with basic EPS losses ranging between US$0.52 and US$0.94. This sets up an earnings story that is centered on loss-making margins and the pace at...

Miami International Holdings FY 2025 earnings snapshot Miami International Holdings (MIAX) has reported a mixed FY 2025 finish, with fourth quarter revenue of US$369.4 million and EPS of US$0.34. The trailing twelve months still reflect a loss of US$70.0 million on revenue of US$1.4 billion and a TTM EPS loss of US$0.82. In recent quarters the company’s quarterly revenue moved from US$323.9 million in Q4 2024 to US$369.4 million in Q4 2025, while EPS shifted from US$0.05 in Q4 2024 to US$0.34...

EVA Live (Nasdaq:GOAI) has launched Fast Quote Direct™, an AI-powered quoting engine designed to automate online lead qualification across financial services, insurance, home services, and other industries.

Simmons First National (SFNC) closed out FY 2025 with fourth quarter revenue of US$233.9 million and basic EPS of US$0.54, following a turbulent year in which trailing twelve month figures show revenue of US$37.4 million and a basic EPS loss of US$2.96. Over recent quarters, the company has seen quarterly revenue move from US$162.7 million in Q3 2024 to US$195.2 million in Q4 2024, then to US$182.8 million, US$202.2 million and US$233.9 million through Q1 to Q4 2025. Basic EPS shifted from...

Chime Financial (CHYM) closed out FY 2025 with Q4 revenue of US$596.4 million and a basic EPS loss of US$0.12. Trailing 12 month figures show revenue of about US$2.2 billion and a basic EPS loss of US$4.27, keeping the story firmly in loss-making territory. Over recent periods the company has seen revenue move from US$475.2 million in Q4 2024 to US$596.4 million in Q4 2025. This has come alongside quarterly EPS that has swung between a profit of US$0.20 in Q1 2025 and a loss of US$7.29 in Q2...

Agilent Technologies (A) has opened fiscal Q1 2026 with revenue of US$1.8b and basic EPS of US$1.08, setting the tone against a trailing twelve month picture that shows US$7.1b in revenue and EPS of US$4.55. Over the past year, the company has seen quarterly revenue move from US$1.70b in Q4 2024 to US$1.86b in Q4 2025 and then to US$1.80b in Q1 2026. Basic EPS shifted from US$1.23 to US$1.53 and now US$1.08, leaving investors focused on how the 18.3% trailing net margin shapes the quality of...

Globus Medical (GMED) just closed out FY 2025 with Q4 revenue of US$826.4 million and basic EPS of US$1.05. Trailing twelve month revenue reached about US$2.9 billion and EPS came in at US$3.98, setting the stage for a sharply different earnings profile compared with a year earlier. Over the past six quarters, the company has seen quarterly revenue move from US$625.7 million in Q3 2024 to US$826.4 million in Q4 2025, with basic EPS shifting from US$0.38 to US$1.05 across the same period. This...